Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 Secondary Progressive Multiple Sclerosis Drug Industry
Figure Secondary Progressive Multiple Sclerosis Drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Secondary Progressive Multiple Sclerosis Drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Secondary Progressive Multiple Sclerosis Drug
1.2.2 Downstream
Table Application Segment of Secondary Progressive Multiple Sclerosis Drug
Table Global Secondary Progressive Multiple Sclerosis Drug Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Secondary Progressive Multiple Sclerosis Drug Market by Type
3.1 By Type
3.1.1 Inebilizumab 
Table Major Company List of Inebilizumab 
3.1.2 GLX-1112 
Table Major Company List of GLX-1112 
3.1.3 DC-TAB 
Table Major Company List of DC-TAB 
3.1.4 Etomoxir 
Table Major Company List of Etomoxir 
3.1.5 IB-MS 
Table Major Company List of IB-MS 
3.1.6 Others
Table Major Company List of Others
3.2 Market Size
Table Global Secondary Progressive Multiple Sclerosis Drug Market 2016-2020, by Type, in USD Million
Figure Global Secondary Progressive Multiple Sclerosis Drug Market Growth 2016-2020, by Type, in USD Million
Table Global Secondary Progressive Multiple Sclerosis Drug Market 2016-2020, by Type, in Volume
Figure Global Secondary Progressive Multiple Sclerosis Drug Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Secondary Progressive Multiple Sclerosis Drug Market Forecast 2021-2026, by Type, in USD Million
Table Global Secondary Progressive Multiple Sclerosis Drug Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 AB Science SA  (Company Profile, Sales Data etc.)
4.1.1 AB Science SA  Profile
Table AB Science SA  Overview List
4.1.2 AB Science SA  Products & Services
4.1.3 AB Science SA  Business Operation Conditions
Table Business Operation of AB Science SA  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Actelion Ltd  (Company Profile, Sales Data etc.)
4.2.1 Actelion Ltd  Profile
Table Actelion Ltd  Overview List
4.2.2 Actelion Ltd  Products & Services
4.2.3 Actelion Ltd  Business Operation Conditions
Table Business Operation of Actelion Ltd  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Biogen, Inc.  (Company Profile, Sales Data etc.)
4.3.1 Biogen, Inc.  Profile
Table Biogen, Inc.  Overview List
4.3.2 Biogen, Inc.  Products & Services
4.3.3 Biogen, Inc.  Business Operation Conditions
Table Business Operation of Biogen, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 F. Hoffmann-La Roche Ltd.  (Company Profile, Sales Data etc.)
4.4.1 F. Hoffmann-La Roche Ltd.  Profile
Table F. Hoffmann-La Roche Ltd.  Overview List
4.4.2 F. Hoffmann-La Roche Ltd.  Products & Services
4.4.3 F. Hoffmann-La Roche Ltd.  Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Genzyme Corporation  (Company Profile, Sales Data etc.)
4.5.1 Genzyme Corporation  Profile
Table Genzyme Corporation  Overview List
4.5.2 Genzyme Corporation  Products & Services
4.5.3 Genzyme Corporation  Business Operation Conditions
Table Business Operation of Genzyme Corporation  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Glialogix, Inc.  (Company Profile, Sales Data etc.)
4.6.1 Glialogix, Inc.  Profile
Table Glialogix, Inc.  Overview List
4.6.2 Glialogix, Inc.  Products & Services
4.6.3 Glialogix, Inc.  Business Operation Conditions
Table Business Operation of Glialogix, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Immune Response BioPharma, Inc.  (Company Profile, Sales Data etc.)
4.7.1 Immune Response BioPharma, Inc.  Profile
Table Immune Response BioPharma, Inc.  Overview List
4.7.2 Immune Response BioPharma, Inc.  Products & Services
4.7.3 Immune Response BioPharma, Inc.  Business Operation Conditions
Table Business Operation of Immune Response BioPharma, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Innate Immunotherapeutics Ltd  (Company Profile, Sales Data etc.)
4.8.1 Innate Immunotherapeutics Ltd  Profile
Table Innate Immunotherapeutics Ltd  Overview List
4.8.2 Innate Immunotherapeutics Ltd  Products & Services
4.8.3 Innate Immunotherapeutics Ltd  Business Operation Conditions
Table Business Operation of Innate Immunotherapeutics Ltd  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Kyorin Pharmaceutical Co., Ltd.  (Company Profile, Sales Data etc.)
4.9.1 Kyorin Pharmaceutical Co., Ltd.  Profile
Table Kyorin Pharmaceutical Co., Ltd.  Overview List
4.9.2 Kyorin Pharmaceutical Co., Ltd.  Products & Services
4.9.3 Kyorin Pharmaceutical Co., Ltd.  Business Operation Conditions
Table Business Operation of Kyorin Pharmaceutical Co., Ltd.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Mallinckrodt Plc  (Company Profile, Sales Data etc.)
4.10.1 Mallinckrodt Plc  Profile
Table Mallinckrodt Plc  Overview List
4.10.2 Mallinckrodt Plc  Products & Services
4.10.3 Mallinckrodt Plc  Business Operation Conditions
Table Business Operation of Mallinckrodt Plc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 MedDay SA  (Company Profile, Sales Data etc.)
4.11.1 MedDay SA  Profile
Table MedDay SA  Overview List
4.11.2 MedDay SA  Products & Services
4.11.3 MedDay SA  Business Operation Conditions
Table Business Operation of MedDay SA  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 MedImmune, LLC  (Company Profile, Sales Data etc.)
4.12.1 MedImmune, LLC  Profile
Table MedImmune, LLC  Overview List
4.12.2 MedImmune, LLC  Products & Services
4.12.3 MedImmune, LLC  Business Operation Conditions
Table Business Operation of MedImmune, LLC  (Sales Revenue, Cost, Gross Margin)
4.13 Merck KGaA  (Company Profile, Sales Data etc.)
4.13.1 Merck KGaA  Profile
Table Merck KGaA  Overview List
4.13.2 Merck KGaA  Products & Services
4.13.3 Merck KGaA  Business Operation Conditions
Table Business Operation of Merck KGaA  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Meta-IQ ApS  (Company Profile, Sales Data etc.)
4.14.1 Meta-IQ ApS  Profile
Table Meta-IQ ApS  Overview List
4.14.2 Meta-IQ ApS  Products & Services
4.14.3 Meta-IQ ApS  Business Operation Conditions
Table Business Operation of Meta-IQ ApS  (Sales Revenue, Cost, Gross Margin)
4.15 Novartis AG  (Company Profile, Sales Data etc.)
4.15.1 Novartis AG  Profile
Table Novartis AG  Overview List
4.15.2 Novartis AG  Products & Services
4.15.3 Novartis AG  Business Operation Conditions
Table Business Operation of Novartis AG  (Sales Revenue, Cost, Gross Margin)
4.16 Opexa Therapeutics, Inc.  (Company Profile, Sales Data etc.)
4.16.1 Opexa Therapeutics, Inc.  Profile
Table Opexa Therapeutics, Inc.  Overview List
4.16.2 Opexa Therapeutics, Inc.  Products & Services
4.16.3 Opexa Therapeutics, Inc.  Business Operation Conditions
Table Business Operation of Opexa Therapeutics, Inc.  (Sales Revenue, Cost, Gross Margin)
4.17 Xenetic Biosciences (UK) Limited (Company Profile, Sales Data etc.)
4.17.1 Xenetic Biosciences (UK) Limited Profile
Table Xenetic Biosciences (UK) Limited Overview List
4.17.2 Xenetic Biosciences (UK) Limited Products & Services
4.17.3 Xenetic Biosciences (UK) Limited Business Operation Conditions
Table Business Operation of Xenetic Biosciences (UK) Limited (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Secondary Progressive Multiple Sclerosis Drug Sales Revenue 2016-2020, by Company, in USD Million
Table Global Secondary Progressive Multiple Sclerosis Drug Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Secondary Progressive Multiple Sclerosis Drug Sales Revenue Share in 2020, by Company, in USD Million
Table Global Secondary Progressive Multiple Sclerosis Drug Sales Volume 2016-2020, by Company, in Volume
Table Global Secondary Progressive Multiple Sclerosis Drug Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Secondary Progressive Multiple Sclerosis Drug Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Secondary Progressive Multiple Sclerosis Drug Market Concentration, in 2020
Figure Europe Secondary Progressive Multiple Sclerosis Drug Market Market Concentration, in 2020
Figure Asia-Pacific Secondary Progressive Multiple Sclerosis Drug MMarket Concentration, in 2020
Figure South America Secondary Progressive Multiple Sclerosis Drug Market Concentration, in 2020
Figure Middle East & Africa Secondary Progressive Multiple Sclerosis Drug Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital 
Figure Secondary Progressive Multiple Sclerosis Drug Demand in Hospital , 2016-2020, in USD Million
Figure Secondary Progressive Multiple Sclerosis Drug Demand in Hospital , 2016-2020, in Volume
6.1.2 Demand in Clinic 
Figure Secondary Progressive Multiple Sclerosis Drug Demand in Clinic , 2016-2020, in USD Million
Figure Secondary Progressive Multiple Sclerosis Drug Demand in Clinic , 2016-2020, in Volume
6.1.3 Demand in Others
Figure Secondary Progressive Multiple Sclerosis Drug Demand in Others, 2016-2020, in USD Million
Figure Secondary Progressive Multiple Sclerosis Drug Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Secondary Progressive Multiple Sclerosis Drug Demand Forecast 2021-2026, by Application, in USD Million
Figure Secondary Progressive Multiple Sclerosis Drug Market Growth 2021-2026, by Application, in USD Million
Figure Secondary Progressive Multiple Sclerosis Drug Market Share in 2026, by Application, in USD Million
Table Secondary Progressive Multiple Sclerosis Drug Demand Forecast 2021-2026, by Application, in Volume
Table Secondary Progressive Multiple Sclerosis Drug Market Growth 2021-2026, by Application, in Volume
Table Secondary Progressive Multiple Sclerosis Drug Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Secondary Progressive Multiple Sclerosis Drug Production 2016-2020, by Region, in USD Million
Table Secondary Progressive Multiple Sclerosis Drug Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Secondary Progressive Multiple Sclerosis Drug Market 2016-2020, by Region, in USD Million
Table Global Secondary Progressive Multiple Sclerosis Drug Market Share 2016-2020, by Region, in USD Million
Table Global Secondary Progressive Multiple Sclerosis Drug Market 2016-2020, by Region, in Volume
Table Global Secondary Progressive Multiple Sclerosis Drug Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2016-2020, in USD Million
Figure North America Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in USD Million
Table North America Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2016-2020, in USD Million
Figure Europe Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in USD Million
Table Europe Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2016-2020, in USD Million
Figure South America Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in USD Million
Table South America Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Secondary Progressive Multiple Sclerosis Drug Market Forecast 2021-2026, by Region, in USD Million
Table Secondary Progressive Multiple Sclerosis Drug Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of Secondary Progressive Multiple Sclerosis Drug
2. Table Application Segment of Secondary Progressive Multiple Sclerosis Drug
3. Table Global Secondary Progressive Multiple Sclerosis Drug Market 2016-2026, by Application, in USD Million
4. Table Major Company List of GLX-1112 
5. Table Major Company List of DC-TAB 
6. Table Major Company List of Etomoxir 
7. Table Major Company List of IB-MS 
8. Table Major Company List of Others
9. Table Global Secondary Progressive Multiple Sclerosis Drug Market 2016-2020, by Type, in USD Million
10. Table Global Secondary Progressive Multiple Sclerosis Drug Market 2016-2020, by Type, in Volume
11. Table Global Secondary Progressive Multiple Sclerosis Drug Market Forecast 2021-2026, by Type, in USD Million
12. Table Global Secondary Progressive Multiple Sclerosis Drug Market Forecast 2021-2026, by Type, in Volume
13. Table AB Science SA  Overview List
14. Table Business Operation of AB Science SA  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Actelion Ltd  Overview List
16. Table Business Operation of Actelion Ltd  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Biogen, Inc.  Overview List
18. Table Business Operation of Biogen, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table F. Hoffmann-La Roche Ltd.  Overview List
20. Table Business Operation of F. Hoffmann-La Roche Ltd.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Genzyme Corporation  Overview List
22. Table Business Operation of Genzyme Corporation  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Glialogix, Inc.  Overview List
24. Table Business Operation of Glialogix, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table Immune Response BioPharma, Inc.  Overview List
26. Table Business Operation of Immune Response BioPharma, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Innate Immunotherapeutics Ltd  Overview List
28. Table Business Operation of Innate Immunotherapeutics Ltd  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Kyorin Pharmaceutical Co., Ltd.  Overview List
30. Table Business Operation of Kyorin Pharmaceutical Co., Ltd.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table Mallinckrodt Plc  Overview List
32. Table Business Operation of Mallinckrodt Plc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
33. Table MedDay SA  Overview List
34. Table Business Operation of MedDay SA  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
35. Table MedImmune, LLC  Overview List
36. Table Business Operation of MedImmune, LLC  (Sales Revenue, Cost, Gross Margin)
37. Table Merck KGaA  Overview List
38. Table Business Operation of Merck KGaA  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
39. Table Meta-IQ ApS  Overview List
40. Table Business Operation of Meta-IQ ApS  (Sales Revenue, Cost, Gross Margin)
41. Table Novartis AG  Overview List
42. Table Business Operation of Novartis AG  (Sales Revenue, Cost, Gross Margin)
43. Table Opexa Therapeutics, Inc.  Overview List
44. Table Business Operation of Opexa Therapeutics, Inc.  (Sales Revenue, Cost, Gross Margin)
45. Table Xenetic Biosciences (UK) Limited Overview List
46. Table Business Operation of Xenetic Biosciences (UK) Limited (Sales Revenue, Cost, Gross Margin)
47. Table Global Secondary Progressive Multiple Sclerosis Drug Sales Revenue 2016-2020, by Company, in USD Million
48. Table Global Secondary Progressive Multiple Sclerosis Drug Sales Revenue Share 2016-2020, by Company, in USD Million
49. Table Global Secondary Progressive Multiple Sclerosis Drug Sales Volume 2016-2020, by Company, in Volume
50. Table Global Secondary Progressive Multiple Sclerosis Drug Sales Volume Share 2016-2020, by Company, in Volume
51. Table Regional Demand Comparison List
52. Table Major Application in Different Regions
53. Table Secondary Progressive Multiple Sclerosis Drug Demand Forecast 2021-2026, by Application, in USD Million
54. Table Secondary Progressive Multiple Sclerosis Drug Demand Forecast 2021-2026, by Application, in Volume
55. Table Secondary Progressive Multiple Sclerosis Drug Market Growth 2021-2026, by Application, in Volume
56. Table Secondary Progressive Multiple Sclerosis Drug Market Share in 2026, by Application, in Volume
57. Table Secondary Progressive Multiple Sclerosis Drug Production 2016-2020, by Region, in USD Million
58. Table Secondary Progressive Multiple Sclerosis Drug Production 2016-2020, by Region, in Volume
59. Table Global Secondary Progressive Multiple Sclerosis Drug Market 2016-2020, by Region, in USD Million
60. Table Global Secondary Progressive Multiple Sclerosis Drug Market Share 2016-2020, by Region, in USD Million
61. Table Global Secondary Progressive Multiple Sclerosis Drug Market 2016-2020, by Region, in Volume
62. Table Global Secondary Progressive Multiple Sclerosis Drug Market Share 2016-2020, by Region, in Volume
63. Table North America Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in USD Million
64. Table North America Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in Volume
65. Table Europe Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in USD Million
66. Table Europe Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in Volume
67. Table Asia-Pacific Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in USD Million
68. Table Asia-Pacific Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in Volume
69. Table South America Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in USD Million
70. Table South America Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in Volume
71. Table Middle East & Africa Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in USD Million
72. Table Middle East & Africa Secondary Progressive Multiple Sclerosis Drug Market Size 2016-2020, by Country, in Volume
73. Table Secondary Progressive Multiple Sclerosis Drug Market Forecast 2021-2026, by Region, in USD Million
74. Table Secondary Progressive Multiple Sclerosis Drug Market Forecast 2021-2026, by Region, in Volume
75. Table Price Factors List